2020
DOI: 10.1071/rdv32n2ab61
|View full text |Cite
|
Sign up to set email alerts
|

61 Low plasma progestin concentration during the early luteal phase impairs equine conceptus development until placentation

Abstract: During the early luteal phase, low progesterone concentrations delay downregulation of endometrial progesterone receptors. This contributes to impaired histotroph production at Day 14 of pregnancy (Beyer et al. 2019 Theriogenology 125, 236-241). Until the beginning of placentation (i.e. Day 37 of pregnancy), nutritional supply of the equine conceptus depends on histotrophy alone. The aim of the present study was to analyse development of the equine conceptus under reduced plasma progesterone concentrations unt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 0 publications
0
9
1
Order By: Relevance
“…Timely progesterone receptor downregulation is an important step in the preparation of the endometrium for early pregnancy and placentation [9,10]. This has also been demonstrated in horses [5,7,11].…”
Section: Introductionmentioning
confidence: 82%
See 4 more Smart Citations
“…Timely progesterone receptor downregulation is an important step in the preparation of the endometrium for early pregnancy and placentation [9,10]. This has also been demonstrated in horses [5,7,11].…”
Section: Introductionmentioning
confidence: 82%
“…When a dominant follicle >35 mm in diameter was detected along with uterine edema, mares were inseminated with raw semen (500 × 10 6 motile spermatozoa) from a fertile stallion at 48-h intervals until spontaneous ovulation (disappearance of the preovulatory follicle) occurred. On the ovulation day (day 0), the mares were randomly assigned to treatment (PGF) with the prostaglandin F2α (PGF 2α ) analogue cloprostenol (125 µg once daily; Estrumate, MSD, Vienna, Austria) from day 0 until day 3 or left untreated as control (CON), as previously described [5,7].…”
Section: Experimental Design and Management Of Maresmentioning
confidence: 99%
See 3 more Smart Citations